Search research articles
Contact Us
Filters
Showing results (41-50 of 44) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 44 results.
Frontiers in Immunology
|
November 13, 2023
An mRNA vaccine against rabies provides strong and durable protection in mice
Miao Li, Enyue Fang, Yunpeng Wang, et al.
Frontiers in Immunology
|
April 3, 2023
Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice
Xingxing Li, Jingjing Liu, Wenjuan Li, et al.
Emerging Microbes & Infections
|
July 1, 2022
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice
Xingxing Li, Ling Wang, Jingjing Liu, et al.
The British Journal of Dermatology
|
February 16, 2026
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Cheng Zhou, Yan Zhao, Guannan Zhu, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 44) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 44 results.
Frontiers in Immunology
|
November 13, 2023
An mRNA vaccine against rabies provides strong and durable protection in mice
Miao Li, Enyue Fang, Yunpeng Wang, et al.
Frontiers in Immunology
|
April 3, 2023
Heterologous prime-boost immunisation with mRNA- and AdC68-based 2019-nCoV variant vaccines induces broad-spectrum immune responses in mice
Xingxing Li, Jingjing Liu, Wenjuan Li, et al.
Emerging Microbes & Infections
|
July 1, 2022
Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice
Xingxing Li, Ling Wang, Jingjing Liu, et al.
The British Journal of Dermatology
|
February 16, 2026
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial
Cheng Zhou, Yan Zhao, Guannan Zhu, et al.
Page
of 5